MoneyWorks4Me

Alembic Pharmaceuticals informs about disclosure

03 Jul 2025 Evaluate

Alembic Pharmaceuticals has informed that Alembic Pharmaceuticals Inc., wholly owned subsidiary of the Company has acquired Utility Therapeutics. The disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding the aforesaid acquisition is enclosed as Annexure – I.

The above information is a part of company’s filings submitted to BSE.



Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..